GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,557,182 | +36.6% | 313,337 | +63.8% | 0.00% | +33.3% |
| Q2 2023 | $11,389,883 | -2.3% | 191,298 | -7.1% | 0.00% | 0.0% |
| Q1 2023 | $11,662,742 | -91.6% | 205,910 | -89.0% | 0.00% | -92.7% |
| Q4 2022 | $139,585,266 | +33.4% | 1,879,430 | +7.0% | 0.04% | +20.6% |
| Q3 2022 | $104,623,000 | -1.4% | 1,756,293 | -7.1% | 0.03% | +6.2% |
| Q2 2022 | $106,089,000 | +12.6% | 1,889,734 | +48.0% | 0.03% | +33.3% |
| Q1 2022 | $94,179,000 | -13.9% | 1,276,487 | -15.7% | 0.02% | -7.7% |
| Q4 2021 | $109,356,000 | +15.2% | 1,514,624 | +22.2% | 0.03% | +8.3% |
| Q3 2021 | $94,933,000 | +18.9% | 1,239,028 | +20.3% | 0.02% | +20.0% |
| Q2 2021 | $79,852,000 | +11.4% | 1,029,951 | -11.4% | 0.02% | +5.3% |
| Q1 2021 | $71,689,000 | +88.5% | 1,162,469 | +99.3% | 0.02% | +72.7% |
| Q4 2020 | $38,035,000 | -12.4% | 583,163 | -33.5% | 0.01% | -26.7% |
| Q3 2020 | $43,396,000 | -15.1% | 876,319 | -18.2% | 0.02% | -16.7% |
| Q2 2020 | $51,143,000 | +147.0% | 1,071,936 | +120.1% | 0.02% | +100.0% |
| Q1 2020 | $20,709,000 | -18.0% | 486,917 | +13.5% | 0.01% | +12.5% |
| Q4 2019 | $25,258,000 | +5.0% | 428,967 | -8.9% | 0.01% | +33.3% |
| Q3 2019 | $24,059,000 | -9.3% | 470,635 | -24.9% | 0.01% | -14.3% |
| Q2 2019 | $26,526,000 | +48.2% | 627,072 | +73.1% | 0.01% | +16.7% |
| Q1 2019 | $17,900,000 | +54.3% | 362,282 | +35.2% | 0.01% | +50.0% |
| Q4 2018 | $11,601,000 | -14.3% | 268,035 | +12.3% | 0.00% | 0.0% |
| Q3 2018 | $13,544,000 | +14.3% | 238,611 | +1.6% | 0.00% | 0.0% |
| Q2 2018 | $11,849,000 | +655.7% | 234,819 | +646.2% | 0.00% | +300.0% |
| Q1 2018 | $1,568,000 | -17.1% | 31,469 | -31.6% | 0.00% | 0.0% |
| Q4 2017 | $1,891,000 | +42.5% | 46,015 | +3.1% | 0.00% | – |
| Q3 2017 | $1,327,000 | -7.5% | 44,642 | +3.1% | 0.00% | – |
| Q2 2017 | $1,435,000 | +13.6% | 43,279 | +1.5% | 0.00% | – |
| Q1 2017 | $1,263,000 | +67.3% | 42,646 | +40.1% | 0.00% | – |
| Q4 2016 | $755,000 | +8.5% | 30,440 | -1.3% | 0.00% | – |
| Q3 2016 | $696,000 | -98.2% | 30,830 | -98.1% | 0.00% | -100.0% |
| Q2 2016 | $38,618,000 | +2.1% | 1,620,545 | +1.8% | 0.01% | -6.7% |
| Q1 2016 | $37,814,000 | -15.7% | 1,592,131 | -1.2% | 0.02% | -16.7% |
| Q4 2015 | $44,853,000 | +35.1% | 1,612,274 | +0.3% | 0.02% | +28.6% |
| Q3 2015 | $33,205,000 | -23.0% | 1,607,223 | -4.3% | 0.01% | -17.6% |
| Q2 2015 | $43,107,000 | +3.3% | 1,679,256 | +1.6% | 0.02% | +6.2% |
| Q1 2015 | $41,722,000 | +5.7% | 1,653,027 | -0.5% | 0.02% | +6.7% |
| Q4 2014 | $39,490,000 | +54.0% | 1,661,364 | +27.4% | 0.02% | +50.0% |
| Q3 2014 | $25,646,000 | -19.5% | 1,303,796 | -2.1% | 0.01% | -23.1% |
| Q2 2014 | $31,872,000 | +5.6% | 1,332,397 | +17.4% | 0.01% | +8.3% |
| Q1 2014 | $30,181,000 | +2154.0% | 1,135,049 | +1610.7% | 0.01% | +1100.0% |
| Q4 2013 | $1,339,000 | +2810.9% | 66,351 | +2408.5% | 0.00% | – |
| Q3 2013 | $46,000 | -95.5% | 2,645 | -95.7% | 0.00% | – |
| Q2 2013 | $1,031,000 | – | 61,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |